Treatments that interfere with the intercellular transport of exosomes may also be beneficial, as demonstrated by Tongxinluo treatment in DKD, which inhibits renal fibrosis by blocking TGF-β1 transport via exosomes [80]. Here, TGFB1 is linked to diabetic kidney disease.